Please assess the completion status of the following clinical trial:

Trial Title: Rapid Assessment of Esophageal Adenocarcinoma Risk Test

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Males:~Ages 50-75 and at least one of the following:~* Gastro-esophageal reflux disease (GERD)\* or~* Family history (first degree relative) with Barrett's esophagus or esophageal adenocarcinoma or~* Both body mass index (BMI) ≥30 or~* A history of cigarette smoking (at least 10 pack years)~Females:~Ages 50-75 and GERD\* and at least one of the following:~* Family history (first degree relative) with Barrett's esophagus or esophageal adenocarcinoma or~* BMI ≥30 or~* A history of cigarette smoking (at least 10 pack years)~Exclusion Criteria:~* History of gastric or esophageal cancer~* History of esophageal surgery~* Known untreated esophageal stricture or uninvestigated dysphagia~* Previous upper endoscopy within 10 years~* Cancer within 3 years except for non-melanoma skin cancer~* Portal hypertension, with or without known varices~* Uncontrolled coagulopathy~* Uncontrolled major comorbid illness~* Inability to tolerate or contraindication to upper endoscopy~* Inability to give informed consent~GERD defined as either a history of frequent heartburn or fluid regurgitation symptoms (at least weekly for 6 months) or regular use of proton pump inhibitors or histamine-2 receptor antagonists.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Cytosponge Test (Type: OTHER): This arm will include individuals without formal diagnosis of Barrett's esophagus.

Based on this trial design, predict the completion outcome and termination type (if applicable).